|1.||Thase, Michael E: 6 articles (10/2014 - 02/2007)|
|2.||Tohen, Mauricio: 5 articles (10/2014 - 01/2004)|
|3.||Case, Michael: 5 articles (06/2011 - 05/2005)|
|4.||Citrome, Leslie: 4 articles (12/2014 - 12/2011)|
|5.||Vieta, Eduard: 4 articles (06/2012 - 01/2007)|
|6.||Fountoulakis, Konstantinos N: 4 articles (06/2012 - 01/2007)|
|7.||Corya, Sara A: 4 articles (02/2007 - 05/2005)|
|8.||Ketter, Terence A: 3 articles (12/2014 - 05/2005)|
|9.||Briggs, Susan D: 3 articles (09/2007 - 05/2005)|
|10.||Landry, John: 2 articles (03/2015 - 10/2014)|
|1.||Bipolar Disorder (Mania)
12/01/2011 - "This treatment evaluation reviews double-blind randomized controlled trials of olanzapine-fluoxetine combination for bipolar depression. "
03/01/2015 - "To assess the efficacy and safety of olanzapine/fluoxetine combination (OFC) for the acute treatment of bipolar depression in children and adolescents. "
12/01/2011 - "Olanzapine-fluoxetine combination is one of only two products currently approved by the US FDA for the acute treatment of depressive episodes associated with bipolar disorder. "
12/01/2011 - "Olanzapine-fluoxetine combination for the treatment of bipolar depression."
05/01/2006 - "The present findings suggest that long-term treatment with olanzapine-fluoxetine combination may be a useful option for the management of depressive symptoms and carries a low risk of mania emergence."
06/01/2011 - "Early weight gain as a predictor of substantial weight gain with olanzapine/fluoxetine combination: an analysis of 2 adult studies in treatment-resistant depression."
06/01/2011 - "Weight gain during olanzapine/fluoxetine combination (OFC) therapy is very common. "
12/01/2011 - "When contrasted with lamotrigine, olanzapine-fluoxetine combination demonstrates statistically significantly greater improvement in depressive and manic symptoms but there is a higher incidence of treatment-emergent adverse events, weight gain and elevation in metabolic factors. "
12/01/2014 - "NNH values less than 10 (vs placebo) were observed for the spontaneously reported adverse events of weight gain and diarrhea for olanzapine/fluoxetine combination (7 and 9, respectively) and somnolence and dry mouth for quetiapine (3 and 4, respectively). "
12/01/2014 - "The 2 older FDA-approved treatments for bipolar depression, olanzapine-fluoxetine combination (OFC) and quetiapine (QTP) monotherapy, were efficacious (response NNT=4 for OFC, NNT=6 for QTP), but similarly likely to yield harms (OFC weight gain NNH=6; QTP sedation/somnolence NNH=5). "
|3.||Major Depressive Disorder (Major Depressive Disorders)
12/01/2014 - "The objective of the study was to explore the effects of olanzapine-fluoxetine combination (OFC) treatment of major depressive disorders on the quality of life in the acute treatment period. "
12/01/2014 - "Effects of olanzapine-fluoxetine combination treatment of major depressive disorders on the quality of life during acute treatment period."
10/01/2005 - "This 8-week, double-blind, multicenter study was undertaken to replicate, in a larger sample of patients with treatment-resistant major depressive disorder (MDD; DSM-IV criteria), the results of a pilot study of the olanzapine/fluoxetine combination. "
10/01/2014 - "Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder."
06/01/2012 - "A post hoc analysis of a priori-selected SNPs used data from a clinical trial (dates: April 2002-July 2005) of olanzapine-fluoxetine combination, fluoxetine, and olanzapine in patients with major depressive disorder (DSM-IV criteria) and with nonresponse to prestudy antidepressant treatment and nonresponse to fluoxetine treatment during the study. "
|4.||Depressive Disorder (Melancholia)
02/01/2009 - "Despite FDA approval of both the olanzapine-fluoxetine combination and quetiapine for the treatment of acute bipolar depression, independent RCTs (i.e., not trials conducted 'under the umbrella' of a drug company) have not found any drug to have antidepressant effects similar to those seen in unipolar depression. "
|5.||Borderline Personality Disorder (Personality Disorders, Borderline)
07/01/2004 - "A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder."
07/01/2004 - "The intent of this study was to compare the efficacy and safety of fluoxetine, olanzapine, or the olanzapine-fluoxetine combination (OFC) in the treatment of women meeting criteria for borderline personality disorder (without concurrent major depressive disorder). "
|3.||N- (2- (4- (1,2- benzisothiazol- 3- yl)- 1- piperazinylmethyl)- 1- cyclohexylmethyl)- 2,3- bicyclo(2.2.1)heptanedicarboximide
|7.||Valproic Acid (Valproate, Semisodium)
|9.||Risperidone (Risperdal Consta)
|10.||Antipsychotic Agents (Antipsychotics)